296
Views
12
CrossRef citations to date
0
Altmetric
Research Article

Maternal antihypertensive drugs may influence cerebral oxygen extraction in preterm infants during the first days after birth

, , &
Pages 871-876 | Received 05 Jun 2012, Accepted 10 Jan 2013, Published online: 06 Feb 2013
 

Abstract

Objective: To determine whether maternal antihypertensive drugs influenced cerebral oxygenation in preterm infants during the first days after birth.

Methods: We included 49 preterm infants (median gestational age 30.3 weeks, (range 26.0–31.9), birth weight 1250 g (560–2250)). Regional cerebral oxygen saturation (rcSO2) was measured by near-infrared spectroscopy on postnatal days 1, 2, 3, 4 and 5. Fractional tissue oxygen extraction (FTOE) was calculated using rcSO2 and arterial oxygen saturation (SpO2) values:(SpO2 − rcSO2)/SpO2.

Results: Nine mothers were treated with labetalol and/or MgSO4 during pregnancy, three mothers with labetalol, MgSO4 and nifedipine, and 19 mothers with nifedipine only. Eighteen infants served as controls. Multivariate linear regression analysis showed that exposure to labetalol and/or MgSO4 during pregnancy decreased FTOE on day 1 after birth, while nifedipine did not.

Conclusions: Treating pregnant women with labetalol and/or MgSO4 may influence cerebral oxygen extraction in their offspring shortly after birth.

Acknowledgements

We greatly acknowledge the help of Joke Ravisé for data collection. We also greatly acknowledge the help of Dr Titia Brantsma – van Wulfften Palthe in Utrecht for correcting the English manuscript.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.